🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A multicentre, randomised, double-blind,4-stages phase III study enrolled 4...
Status
Completed
Location
Union Hospital Tongji Medical College Huazhong University of Science and technology
Start Date
2017-06-30
Trial ID
NCT03222843
Treatments Being Tested
This is a multicenter, randomized, placebo-control, phase III study to inve...
Status
Completed
Location
Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2019-03-05
Trial ID
NCT03825744
Treatments Being Tested
This is a multicenter, placebo-control, phase 3 study of hetrombopag in pat...
Status
Active Not Recruiting
Location
Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2019-09-19
Trial ID
NCT04961710
Treatments Being Tested
Hetrombopag Olamine made by Jiangsu Hengrui Medicine co Ltd. has shown an e...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2012-04
Trial ID
NCT01830660
Treatments Being Tested
The study is being conducted to evaluate the efficacy, and safety of of Het...
Status
Recruiting
Location
Cancer and Blood Specialty Clinic
Start Date
2026-04-16
Trial ID
NCT07286032
Treatments Being Tested
The study is aimed to evaluate the efficacy of different doses of hetrombop...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-04-15
Trial ID
NCT05261646
Treatments Being Tested